Das Paromita, Lilly Scott M, Zerda Ricardo, Gunning William T, Alvarez Francisco J, Tietz Elizabeth I
Department of Physiology and Pharmacology, University of Toledo College of Medicine, Health Science Campus, Toledo, Ohio 43614, USA.
J Comp Neurol. 2008 Dec 20;511(6):832-46. doi: 10.1002/cne.21866.
Prolonged benzodiazepine treatment leads to tolerance and increases the risk of dependence. Flurazepam (FZP) withdrawal is associated with increased anxiety correlated with increased alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptor (AMPAR)-mediated synaptic function and AMPAR binding in CA1 pyramidal neurons. Enhanced AMPAR synaptic strength is also associated with a shift toward inward rectification of synaptic currents and increased expression of GluR1, but not GluR2, subunits, suggesting augmented membrane incorporation of GluR1-containing, GluR2-lacking AMPARs. To test this hypothesis, the postsynaptic incorporation of GluR1 and GluR2 subunits in CA1 neurons after FZP withdrawal was examined by postembedding immunogold quantitative electron microscopy. The percentage of GluR1 positively labeled stratum radiatum (SR) synapses was significantly increased in FZP-withdrawn rats (88.2% +/- 2.2%) compared with controls (74.4% +/- 1.9%). In addition, GluR1 immunogold density was significantly increased by 30% in SR synapses in CA1 neurons from FZP-withdrawn rats compared with control rats (FZP: 14.1 +/- 0.3 gold particles/mum; CON: 10.8 +/- 0.4 gold particles/mum). In contrast, GluR2 immunogold density was not significantly different between groups. Taken together with recent functional data from our laboratory, the current study suggests that the enhanced glutamatergic strength at CA1 neuron synapses during benzodiazepine withdrawal is mediated by increased incorporation of GluR1-containing AMPARs. Mechanisms underlying synaptic plasticity in this model of drug dependence are therefore fundamentally similar to those that operate during activity-dependent plasticity.
长期使用苯二氮䓬类药物治疗会导致耐受性增加,并增加成瘾风险。氟西泮(FZP)戒断与焦虑增加相关,这与α-氨基-3-羟基-5-甲基-4-异恶唑丙酸型谷氨酸受体(AMPAR)介导的突触功能增强以及CA1锥体神经元中AMPAR结合增加有关。增强的AMPAR突触强度还与突触电流向内整流的转变以及GluR1亚基而非GluR2亚基的表达增加有关,这表明含GluR1、缺乏GluR2的AMPAR在膜上的整合增加。为了验证这一假设,通过包埋后免疫金定量电子显微镜检查了FZP戒断后CA1神经元中GluR1和GluR2亚基的突触后整合情况。与对照组(74.4%±1.9%)相比,FZP戒断大鼠中GluR1阳性标记的辐射层(SR)突触百分比显著增加(88.2%±2.2%)。此外,与对照大鼠相比,FZP戒断大鼠CA1神经元SR突触中的GluR1免疫金密度显著增加了30%(FZP组:14.1±0.3个金颗粒/μm;对照组:10.8±0.4个金颗粒/μm)。相比之下,各组之间的GluR2免疫金密度没有显著差异。结合我们实验室最近的功能数据,本研究表明,苯二氮䓬类药物戒断期间CA1神经元突触处谷氨酸能强度的增强是由含GluR1的AMPAR整合增加介导的。因此,在这种药物依赖模型中,突触可塑性的潜在机制与在活动依赖性可塑性过程中起作用的机制基本相似。